{"id":1148478,"date":[{"year":1998,"month":5,"day":21}],"page":"6","source":"本报","region":"","masthead":"教卫新闻","special_issue":"","column":"","genre":"","count":"268","ytitle":"","mtitle":"首例中药滴丸走向世界","ftitle":"已通过美国FDA临床用药申请","authors":[],"text":[{"type":"paragraph","text":"本报讯　“我国中药如何实现国际化——中国首例中药天士力复方丹参滴丸通过美国FDA临床用药申请研讨会”，昨天在沪举行。出席会议的医药专家认为，发挥中药优势，加快中药研究步伐，促进中药走向世界是中医药事业面临的迫切任务。"},{"type":"paragraph","text":"据与会专家介绍，目前我国中药出口额只占全球草药贸易的3.3%左右，且78%以上是中药材出口。“天士力复方丹参滴丸”主要表现在对心绞痛的治疗效果明显优于同类药，其以药品形式通过美国FDA临床用药申请，实现了中药国际化零的突破。为我国中药产业走向国际化提供了宝贵的经验。"}]}